Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Operating Leases (2016 - 2024)

Historic Operating Leases for HUTCHMED (China) (HCM) over the last 6 years, with Q4 2024 value amounting to $325000.0.

  • HUTCHMED (China)'s Operating Leases fell 8863.64% to $325000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $325000.0, marking a year-over-year decrease of 8863.64%. This contributed to the annual value of $325000.0 for FY2024, which is 8863.64% down from last year.
  • Latest data reveals that HUTCHMED (China) reported Operating Leases of $325000.0 as of Q4 2024, which was down 8863.64% from $2.9 million recorded in Q4 2023.
  • Over the past 5 years, HUTCHMED (China)'s Operating Leases peaked at $6.5 million during Q1 2021, and registered a low of -$874000.0 during Q1 2020.
  • For the 5-year period, HUTCHMED (China)'s Operating Leases averaged around $2.9 million, with its median value being $2.9 million (2023).
  • Data for HUTCHMED (China)'s Operating Leases shows a peak YoY increase of 233564.36% (in 2020) and a maximum YoY decrease of 12738.95% (in 2020) over the last 5 years.
  • HUTCHMED (China)'s Operating Leases (Quarter) stood at $2.3 million in 2020, then skyrocketed by 36.36% to $3.1 million in 2021, then decreased by 12.28% to $2.7 million in 2022, then rose by 5.89% to $2.9 million in 2023, then tumbled by 88.64% to $325000.0 in 2024.
  • Its Operating Leases stands at $325000.0 for Q4 2024, versus $2.9 million for Q4 2023 and $2.7 million for Q4 2022.